Literature DB >> 11853404

A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2.

Steffi Boeckle1, Herbert Pfister, Gertrud Steger.   

Abstract

Repression of transcription by the full-length E2 protein of papillomaviruses (PV) seems to occur when the E2 binding sites and those of positively acting cellular factors overlap. Previously, we showed that RUNX1 (formerly called CBF) binds to the repression-mediating E2 binding site P2 of human PV type 8 (HPV8). By a yeast one-hybrid system we could identify an unknown protein binding also to P2, tentatively called PBF (papillomavirus binding factor). PBF recognizes the sequence CCGG, which represents the 3' half of the E2 binding site just adjacent to the RUNX1 motif. PBF also binds to the repression-mediating E2 BS-1 in BPV1, which is conserved to P2 of HPV8. Point mutations destroying PBF binding to HPV8 P2 and BPV-1 E2 BS-1 in vitro reduce promoter activity in corresponding reporter constructs. Our results suggest that PBF might play a role in transcription of PV genes and in E2-mediated repression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853404     DOI: 10.1006/viro.2001.1231

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  The glucose transporter (GLUT4) enhancer factor is required for normal wing positioning in Drosophila.

Authors:  Umar Yazdani; Zhiyu Huang; Jonathan R Terman
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

3.  RUNX1 permits E4orf6-directed nuclear localization of the adenovirus E1B-55K protein and associates with centers of viral DNA and RNA synthesis.

Authors:  Leslie J Marshall; Amy C Moore; Misao Ohki; Issay Kitabayashi; David Patterson; David A Ornelles
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

4.  Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.

Authors:  Tomohide Tsukahara; Makoto Emori; Kenji Murata; Takahisa Hirano; Norihiro Muroi; Masanori Kyono; Shingo Toji; Kazue Watanabe; Toshihiko Torigoe; Vitaly Kochin; Hiroko Asanuma; Hiroshi Matsumiya; Keiji Yamashita; Tetsuo Himi; Shingo Ichimiya; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa; Noriyuki Sato
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

5.  Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes.

Authors:  Monika Oldak; Radoslaw B Maksym; Tanya Sperling; Moshe Yaniv; Hans Smola; Herbert J Pfister; Jacek Malejczyk; Sigrun Smola
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

6.  A unique DNA binding domain converts T-cell factors into strong Wnt effectors.

Authors:  Fawzia A Atcha; Adeela Syed; Beibei Wu; Nate P Hoverter; Noriko N Yokoyama; Ju-Hui T Ting; Jesus E Munguia; Harry J Mangalam; J Lawrence Marsh; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2007-09-24       Impact factor: 4.272

7.  The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes.

Authors:  Monika Oldak; Hans Smola; Monique Aumailley; Francisco Rivero; Herbert Pfister; Sigrun Smola-Hess
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Cloning and characterization of a novel MyoD enhancer-binding factor.

Authors:  Masakazu Yamamoto; Christopher D Watt; Ryan J Schmidt; Unsal Kuscuoglu; Roger L Miesfeld; David J Goldhamer
Journal:  Mech Dev       Date:  2007-07-10       Impact factor: 1.882

9.  The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.

Authors:  Michael J Lace; James R Anson; Gregory S Thomas; Lubomir P Turek; Thomas H Haugen
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

10.  The hypoxia-inducible transcription factor ZNF395 is controlled by IĸB kinase-signaling and activates genes involved in the innate immune response and cancer.

Authors:  Darko Jordanovski; Christine Herwartz; Anna Pawlowski; Stefanie Taute; Peter Frommolt; Gertrud Steger
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.